Infinity Pharma (INFI) Tops Q2 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. META
5. SPY
6. ANT
7. INTC
8. JBLU
9. NVDA
10. AAPL

Go back to Infinity Pharma (INFI) Tops Q2 EPS by 8c

Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results

August 7, 2018 4:05 PM EDT

CAMBRIDGE, Mass., Aug. 7, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its second quarter 2018 financial results and provided an update on the company, including its progress with IPI-549, a first-in-class oral immuno-oncology product candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma) and targets immune-suppressive tumor macrophages/myeloid-derived suppressor cells (MDSCs).

"We are particularly pleased to welcome Sam Agresta to the Infinity team as Chief Medical Officer. Sam brings extensive experience in novel oncology drug development, having... More